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Abstract 
 
Aims and Background: 
Dementia, a common illness among older people, is diagnosed through a combination of clinical 
assessment, cognitive assessment tools, and neuroimaging.  The aim of this retrospective, 
naturalistic study was to explore the association between the clinical assessment tools used in a 
memory clinic and the findings of Magnetic Resonance Imaging (MRI) scans in patients receiving a 
formal dementia diagnosis.   
Methods:   
Data was collected as part of routine clinical practice for all patients assessed at a memory 
assessment clinic in East Sussex, UK.  Included patients had an MRI scan and received a formal 
diagnosis of dementia following assessment.  Cerebrovascular and atrophy findings on MRI were 
quantified using visual analogue scales.  Multinomial logistic regression analysis was used to 
investigate the associations between atrophy on MRI with age, gender, Cambridge Cognitive 
Examination (CAMCOG), and Hachinski Ischemic Score (HIS).  Ordinal logistic regression analysis was 
used to study the associations between vascular findings on MRI with age, gender, CAMCOG, and 
HIS. 
Results: 
Male gender was associated with an increased likelihood of moderate atrophy (Relative Risk Ratio 
(RRR)=1.92, p=0.048), severe atrophy (RRR=3.03, p=0.006) and regional atrophy (RRR=2.24, p=0.006) 
on MRI.  Higher CAMCOG scores were associated with decreased risk of regional (RRR=0.98, 
p=0.028) atrophy on MRI.  There were no significant associations between age, or HIS, and atrophy 
on MRI.  An increase in age of one year was associated with an increase in severity of vascular 
pathology reported on MRI (OR=1.08, p<0.001).  Male gender was associated with reduced severity 
of vascular pathology reported on MRI (OR=0.52, p<0.001).  There were no associations between 
CAMCOG, or HIS, and vascular pathology on MRI.   
Discussion: 
Our data shows that CAMCOG is associated with MRI findings of atrophy and that vascular pathology 
was greater in older patients.  We highlight the importance of using a multi-modal approach in the 
diagnosis of dementia. 
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What’s already known about this topic? What does this article add? 
 
• Atrophic and vascular pathology are known to coexist in patients with Alzheimer’s and 
vascular dementia.   
• Neuroimaging frequently identifies mixed pathology that may not be identified through 
clinical assessment and enables clinicians to detect or rule out rarer causes of memory 
impairment.  
• We quantify the ability of two common clinical assessment tools to predict dementia 
pathology detected on MRI.  Our findings confirm the importance of neuroimaging in the 
diagnosis of dementia. 
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Introduction 
 
Dementia is a common illness especially among older people.  In the UK the mean age standardised 
prevalence of late-onset dementia in those aged over 65 is 7.1%1. Dementia comprises a host of 
neuropathological syndromes the vast majority of which are chronic and irreversible. Dementia 
manifests in a myriad of characteristic symptoms which may include disturbance of memory, 
thinking, orientation, comprehension, calculation, learning capacity, language and judgement and 
lead to a progressive deterioration in every day function 2.  The most prevalent form of dementia by 
far is Alzheimer’s dementia (AD) which accounts for up to two thirds of cases1. The second most 
common form is vascular dementia (VaD) which accounts for 10-20% of all cases. Dementia with 
Lewy Bodies and Frontotemporal Dementia are less common but not infrequently encountered1. 
There are also several rarer types. Mixed type pathologies are also common, with atrophic and 
vascular findings present on neuroimaging in AD and VaD, for example3.   
In the UK the formal diagnosis of dementia is normally undertaken in community memory clinics 
through the use of clinical and collateral history, mental state examination, cognitive assessment 
tools, and neuroimaging.  In our local service the Cambridge Cognitive Examination (CAMCOG) 4 is 
used to assess cognition. Other clinical rating scales used include the modified Hachinski Ischemic 
Score (HIS) which can be helpful in the diagnosis of VaD5.  These clinical assessments are used to 
discriminate between different dementia diagnoses, with neuroimaging used to rule out the 
presence of factors such as tumours and to help in confirming the clinical diagnosis whenever 
possible. MRI is the most commonly used modality of imaging for investigation of dementia6.  
Validated cognitive assessment tools are used to provide measures of specific clinical components in 
dementia, however, it remains unclear how well these assessments correlate with the expected 
pathology on MRI imaging. 
In the present study, we aim to explore the relationship between these cognitive/clinical assessment 
tools and magnetic resonance imaging (MRI) findings in those diagnosed with a dementia illness. To 
our knowledge this is one of the largest naturalistic studies to assess correlations between cognitive 
and neuropsychiatric assessments, and MRI findings in dementia.  
Objectives 
 
The objective of this retrospective, naturalistic study was to explore the association between the 
clinical assessment tools used in a memory clinic and the findings of MRI scans in patients receiving a 
formal dementia diagnosis.  We hypothesised that worse performance on the CAMCOG would 
predict increased levels of atrophy, whilst positive scores on the HIS would predict increased levels 
of vascular pathology.  
Methods 
 
Study design and setting 
 
The present study is a naturalistic retrospective cross-sectional study of patients with a diagnosis of 
dementia.  Data were collected at the time of assessment as part of routine clinical practice at a 
memory assessment clinic in East Sussex, UK.  Patients were referred for assessment and treatment 
by their general practitioner due to memory complaints between 2004 and 2011. All investigations 
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following referral to the service, including MRI scans, were completed as part of the routine clinical 
practice of the memory service. 
Participants 
 




For inclusion patients were required to have received a formal diagnosis of dementia following 
assessment.  Patients receiving a diagnosis of Alzheimer’s dementia, vascular dementia, mixed 
dementia, dementia with Lewy Bodies, frontotemporal dementia and Parkinson’s dementia were 
included in the study.  For inclusion, patients were required to have had an MRI scan of the brain 
completed by the local neuroradiology centre.  
Exclusion Criteria 
 
To ensure consistency of reporting, patients who had an MRI scan of the brain at another centre 
were excluded. Likewise, patients with missing or incomplete MRI outcome data for atrophy findings 
or vascular pathology were also excluded from the study as were those who had a CT scan instead.  
Clinical Diagnosis 
Clinical diagnoses of dementia were made using the criteria of the Diagnostic and Statistical Manual 
of Mental Disorders, fourth edition (DSM-IV)7. 
Outcome Measure 
 
The outcome measure in this study was the presence atrophy and vascular pathology on MRI.  
Images used by the clinic were all obtained at a single imaging centre and evaluated for the level of 
abnormalities by one of three consultant neuroradiologists. Magnetic resonance images were 
graded according to a qualitative visual assessment of both cerebral atrophy and cerebrovascular 
disease (CVD), which is routinely used to assess patients in a purely clinical setting. 
For findings of atrophy, the neuroradiologist visually estimated the extent of these findings.  The 
location and degree of atrophy were qualitatively characterised into 10 subgroups based on the 
distribution and severity of atrophic changes: no atrophy, minor generalised atrophy, moderate 
generalised atrophy, severe generalised atrophy, frontotemporal atrophy, temporal or 
frontoparietal atrophy, parietal or frontoparietal atrophy, frontal atrophy, occipital atrophy and 
hippocampal atrophy.  Due to the small size of some groups, regional atrophy (frontotemporal 
atrophy, temporal or frontoparietal atrophy, parietal or frontoparietal atrophy, frontal atrophy, 
occipital atrophy and hippocampal atrophy) was grouped together for the purpose of analysis.   
For cerebrovascular findings, the neuroradiologist visually estimated the extent of these findings. 
Based on the number and extent of lacunes, periventricular hyperintensities, deep white matter 
hyperintensities, microinfarcts and cerebrovascular lesions, patients were qualitatively categorised 
into four subgroups of cerebrovascular findings: none, mild, moderate and severe. 
Predictor Variables 
 
The predictor variables in this study are based on the clinical assessment tools routinely used in the 
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memory assessment service.  The Cambridge Cognitive Examination (CAMCOG) was used to measure 
global cognitive status4. The modified Hachinski Ischemic Score (HIS) is used as a measure of the 
likelihood of vascular pathology based on the nature of dementia presentation and vascular risk 
factors5.  Clinically a score of 4 or greater on the HIS is indicative of a diagnosis of vascular dementia.  
Age and sex were included as potential confounding variables.  
Statistical Analysis: 
 
Data were summarised using descriptive statistics and graphical methods.  Due a zero inflated 
distribution of scores on the HIS, and the low frequency of patients scoring above the clinical cut-off 
of 4 or greater in our study population, we treated the HIS as a binary predictor with a cut-off of 1 or 
greater.   
Multinomial logistic regression analysis was used to investigate the associations between atrophy on 
MRI with age, gender, CAMCOG, and HIS.  Ordinal logistic regression analysis was used to study the 
associations between vascular findings on MRI with age, gender, CAMCOG, and HIS. Relative risk 
ratios (RRR) are reported from the multinomial logistic regression and odds ratios (OR) from the 
ordinal logistic regression, together with  95% confidence intervals.  P-values < 0.05 were considered 
significant.  The proportional odds assumption for the ordinal regression analysis was checked and 
no evidence of violation was identified. 
Statistical analysis was performed using R version 3.3.28.  The ‘multinom’ function from the ‘nnet’ 
package was used for multinomial logistic regression9.  The ‘polr’ function from the ‘mass’ package 






Study participants were drawn from a clinical database containing all patients (n = 652) assessed by 
the memory assessment service between 2004 and 2011.  A flow diagram of study eligibility and 
exclusion is shown in figure 1.  Of the patients assessed by the service during study interval, 502 
patients (77%) received a diagnosis of dementia and were eligible for the study.  Patients that did 
not receive a diagnosis of a neurodegenerative disorder or vascular dementia were therefore not 
eligible for the study. Such patients were mainly diagnosed with one of the following conditions:  
depression, intracranial tumour, alcoholic dementia, mild cognitive impairment, or normal pressure 
hydrocephalus.   
A total of 33 patients were excluded from the study because either MRI was carried out at another 
imaging centre, patients were not suitable for MRI scanning (e.g. metal implant), were unable to 
tolerate it or had a CT scan instead. A total of 469 patients were therefore included in the study.  
Descriptive Data 
 
The study population comprised 204 male patients (43.5%), 252 females (53.7%). The gender of the 
remaining 13 patients was not recorded.  The mean age of male participants was 79.1 years (SD = 
6.53, range = 60 to 99), whilst the mean age of female participants was 79.7 years (SD = 6.6, range = 
61 to 93). 
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Patients in the study were diagnosed with a range of dementia diagnoses, most frequently 
Alzheimer’s dementia (62.5%), vascular dementia (15.1%), and mixed dementia (15.4%).  Table 1 
shows the distribution of all dementia diagnoses within the study cohort.   
CAMCOG data was available for 431 patients, with 38 patients having missing data.  The mean score 
on the CAMCOG was 73.0 (SD = 12.8, interquartile range (IQR) = 65.5 to 83.0).  CAMCOG data 
approximated a normal distribution.  HIS data was available for 433 patients, with 36 patients having 
missing data. The mean on the HIS was 0.64 (SD = 1.44, range = 0 to 14).  The HIS was treated as a 




The counts and percentages of MRI atrophy findings are listed in table 2.   Occipital, frontal and 
frontotemporal atrophy occurred infrequently and therefore were grouped with temporal, parietal, 
or frontoparietal atrophy as a single outcome of regional atrophy in the regression analyses.  Table 3 
lists the specific regional findings reported in the patient cohort.  The counts and percentages of 
vascular findings are listed in table 4.   
The presence or absence of other findings detected on MRI imaging were also recorded for most 




Logistic regression of findings of atrophy on MRI imaging on age, gender, CAMCOG, HIS are 
presented in table 6.  Odds of atrophy are expressed relative to no atrophy as the reference level.  
Male gender was associated with an increased likelihood of moderate atrophy (RRR = 1.92, p = 
0.048), severe atrophy (RRR = 3.03, p = 0.006) and regional atrophy (RRR = 2.24, p = 0.006) on MRI.  
Higher CAMCOG scores were associated with decreased odds of regional (RRR = 0.98, p = 0.028) 
atrophy on MRI.  There was no significant association between age, or HIS (0 or ≥ 1), and findings of 
atrophy on MRI imaging.  The effect of CAMCOG, gender, and HIS on MRI findings of atrophy is 
demonstrated in a probability plot calculated from the parameters of the logistic regression model in 
figure 2.    
Ordinal regression of findings of vascular pathology on MRI imaging on age, gender, CAMCOG, and 
HIS, are presented in table 7.  An increase in age of one year was associated with an increase in 
severity of vascular pathology reported on MRI (OR = 1.08, p <0.001).  Male gender was associated 
with reduced severity of vascular pathology reported on MRI (OR = 0.52, p <0.001).  Scores on the 
CAMCOG and HIS did not demonstrate any significant association with findings of vascular pathology 
on MRI imaging.   
The effect of age, gender, and HIS on MRI findings of vascular pathology is demonstrated in a 
probability plot calculated from the parameters of the ordinal regression model in Figure 3.    
Discussion 
Key Results 
Our memory assessment clinic made a dementia diagnosis for 77% of patients referred to the 
service with memory difficulties.  Overall, the range and proportion of dementia diagnoses were in 
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keeping with national data, however, the diagnostic rate of Dementia with Lewy bodies was lower 
than what has been reported by some studies1.    
MRI imaging was used as part of the clinic’s diagnostic process in 94% of patients.  MRI imaging was 
used alongside history, examination and clinical assessment tools to guide the clinical diagnosis of 
dementia.  In addition to identification of the atrophic and vascular pathology found in dementia, 
MRI imaging of the study participants also identified 6 patients with tumours, 4 patients with 
haematomas or aneurysms, 3 intracranial cysts and 55 patients with infarction.  In addition to the 
study participants two patients were excluded from the study after receiving primary diagnoses of 
normal pressure hydrocephalus and intracranial tumour; both diagnoses would have been made 
following MRI imaging. 
We found that lower CAMCOG scores (indicative of poor performance) were associated with an 
increased likelihood of severe atrophy on MRI imaging in our population.  CAMCOG scores did not 
demonstrate a significant association with mild, moderate, or regional atrophy, and did not 
demonstrate a significant association with vascular findings.  The association between lower 
CAMCOG scores and severe atrophy was in keeping with our hypothesis.  The association between 
severe atrophy and CAMCOG performance is likely to be stronger than associations with mild and 
moderate atrophy, as patients with severe atrophy demonstrate the highest levels of intra-cranial 
pathology.  
Male gender was associated with increased likelihood of moderate, severe, and regional atrophy on 
MRI imaging in our population.  We found that male gender was associated with reduced severity of 
vascular pathology on MRI imaging in our population.  In our cohort gender therefore appears to 
have a differential effect on atrophic and vascular changes, with males having more atrophic 
pathology, and less vascular pathology.  Gender differences in vascular pathology on MRI imaging 
have previously been reported in a large population of healthy participants aged 60-90; where 
females are suggested to exhibit an increased prevalence of white matter lesions, although these 
results did not reach significance15.   
As expected, we found that increasing age was associated with the likelihood of increased severity of 
vascular pathology on MRI imaging in our population. This is in keeping with published data on 
healthy participants aged 60-9015.  We anticipated finding an increase in atrophic changes with age, 
however, there was no a significant association between age and atrophy.   
No significant associations were detected between the HIS and MRI findings of atrophy or vascular 
pathology, although scope to identify significant associations was limited due to distribution of 
results on the HIS and the small numbers of patients scoring highly on the measure in our study 
population.   
Limitations 
 
The study had a naturalistic and retrospective design, and this limited the data available for the 
study.  Whilst naturalistic studies carry limitations the data they provide is representative of clinical 
practice, and the methodology facilitated the large sample size of the present study.  The decision to 
use CAMCOG and HIS as key predictors was based on the frequency with which the tools were used 
clinically in the memory clinic.  Both CAMCOG and HIS benefit from over 90% completeness in our 
population reflecting high rates of use in the local service.  Whilst the memory clinic uses a number 
of other assessment tools, these are used less frequently in the clinic and due to selective 
deployment of tools by clinicians these would have demonstrated significant sampling bias.   
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Due to the distribution of scores on the HIS within our study population we were unable to use the 
clinical cut-off of 4 or greater as a predictor in the regression models.  Only 20 patients had a 
clinically significant score on the Hachinski across all groups.  Numbers of patients with a clinically 
significant HIS with any given combination of variables were too low to act as predictors in the 
regression model16.  
This study was limited to those patients that were referred to a memory assessment service and 
received a diagnosis of dementia.  This resulted in a restricted range of CAMCOG scores included in 
the study as CAMCOG used by the service as the main cognitive measure to identify dementia. 
Inclusion of healthy age-matched controls and patients with mild cognitive impairment would have 
led to a broader range of CAMCOG scores and may potentially improve the predictive power of the 
tool for atrophy.  
The regional atrophy group consisted of patients 112 with an Alzheimer’s pattern atrophy, 21 
patients with frontotemporal pattern atrophy, and 2 patients with occipital atrophy.  The 
heterogeneity of this group may have impacted on our ability to detect associations that varied 
across the different atrophy patterns.  
This study used a visual analogue measure of atrophic and vascular findings as used in routine 
clinical practice.  The use of a visual analogue measure could be considered a limitation when 
compared with more precise methods such as volumetric analysis.  Despite the limitations, a visual 
analogue approach is used in routine clinical practice and was felt to be an appropriate outcome 
given the naturalistic design of the study.  
In this study 69 patients were found to have missing data (age, gender, HIS or CAMCOG) with these 
patients being excluded from the regression analyses.  Comparison between patients with missing 
and complete data did not find any significant difference between the characteristics of the groups.  
This supports that the missing data is missing completely at random and would not be anticipated to 
have impacted on the outcome of the analysis.  
Interpretation 
 
This is a large study assessing the associations between clinical assessment and MRI confirmed 
pathology findings in dementia patients.  The study benefits from robust neuroimaging conducted at 
a single centre by a small team of senior neuroradiologists.  We found a number of small but 
significant associations between CAMCOG, gender, age and MRI confirmed pathology.  We found 
that both CAMCOG and Hachinski are limited in their ability to predict MRI pathology using our 
methodology.  CAMCOG is used as primary cognitive assessment battery and has a role irrespective 
of predicting atrophy findings. 
The lack of association between CAMCOG scores and the degree of vascular pathology in our study 
was unexpected.  With increasing age we identify increased rates of vascular pathology, but this 
does not appear to correspond with worsening CAMCOG performance.  This raises the question of 
what impact the vascular damage has in these individuals, and whether, they have a mixed, vascular 
or Alzheimer’s dementia picture.  Given vascular pathology is known to increase with age in healthy 
individuals, it is possible in some individuals that the vascular pathology identified on MRI is related 
to normal ageing rather than contributing to cognitive decline15.   
Our data did not conform to the known role of the HIS in the diagnostic process in differentiating 
Alzheimer’s and vascular dementia17.  Whilst we were unable to use the clinical cut-off of the HIS in 
the regression analyses, we were able to look at the descriptive data using the clinical cut-off. Using 
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the clinical cut-off of HIS greater than 4 we identified 20 patients (4.3%) reaching the clinical 
threshold yet identified 71 patients (15.1%) with Vascular Dementia.  In patients with a HIS greater 
than 4 we found 5 (25%) patients received a clinical diagnosis of Alzheimer’s dementia, and 1 (5%) 
received a diagnosis of Parkinson’s dementia. This supports the understanding that cerebrovascular 
pathology can frequently co-exist with a host of neurodegenerative disorders3.  
In our service the HIS is calculated prior to completion of neuroimaging and given that 55 (11.7%) 
patients were found to have infarction on MRI imaging this may have led to underestimates of the 
true scores.  Measures were completed by a range of clinicians in the memory clinic which may have 
led to inter-rater differences and variation in the application of the measure18.  This may have 
reduced the utility of the HIS in our population versus data from clinical trials. 
Whilst clinical assessment tools have only limited ability to predict MRI outcomes, we found a range 
of clinically significant pathology on MRI scans within our population supporting the ongoing role of 
MRI scanning in the memory clinic.   MRI imaging alone has only limited utility without interpreting it 
with the rest of the clinical assessment.  
Generalisability 
 
The proportions of dementia diagnoses in our study population are representative of rates in the UK 
population.  The study used a naturalistic methodology and a large sample of patients from the 
South East of England.  The study explored the clinical assessment process in a single memory clinic 
and explored the associations in the data based on the clinical process used in the clinic.  Despite 




In this retrospective naturalistic study we explored the associations between the CAMCOG and HIS 
and MRI findings in dementia.  In keeping with our hypotheses we found data to support an 
association between poor CAMCOG performance and an increase in severe atrophy and a positive 
association between older age and vascular findings.  We also found differential effects of gender on 
vascular and atrophic pathology, and further exploration of these findings is required.  Whilst our 
study did not demonstrate a positive association between HIS and vascular damage the HIS is well 
validated in other populations.  Our data shows that clinical assessment tools demonstrate clear 
associations with MRI findings, however, we highlight the importance of using a multi-modal 
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Table 1: Counts and percentages of dementia diagnoses in study participants 
 
Diagnosis Count Percentage 
Alzheimer’s Dementia 293 62.5 
Dementia with Lewy Bodies 20 4.3 
Frontotemporal dementia 9 1.9 
Mixed Dementia 72 15.4 
Parkinson’s dementia 4 0.9 
Vascular dementia 71 15.1 
Total 469 100.0 
 
Table 2: Degree of atrophy findings on MRI imaging in study participants 
 
Atrophy Location Count Percentage  
No atrophy 121 25.8 
Minor generalised atrophy 87 18.6 
Moderate generalised atrophy 80 17.1 
Severe/major atrophy 46 9.8 
Regional 135 28.8 
Total 469 100.0 
 
Table 3: Distribution of regional atrophy findings on MRI imaging in study participants 
 
Atrophy Location Count Percentage  
Frontal and frontotemporal atrophy 21 15.6 
Occipital atrophy 2 1.5 
Temporal, Parietal or frontoparietal atrophy 112 83.0 
Total 135 100.0 
 
Table 4: Distribution of vascular findings on MRI imaging in study participants 
 
Vascular Findings Count Percentage  
No Vascular 60 12.8 
Mild Vascular 168 35.8 
Moderate Vascular 128 27.3 
Severe Vascular 113 24.1 
Total 469 100.0 
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Table 5: Counts and percentages of other MRI findings detected in study participants 
 
MRI Finding Count Percentage 
No other finding  339 72.9 
Tumour 6 1.3 
Hydrocephalus  2 0.4 
Haematoma/aneurysm 4 0.9 
Infarct 55 11.8 
Sinusitis/polyps 51 11.0 
Intracranial Cyst 3 0.6 
Other 5 1.1 
Total 465 100.0 
 
MRI = Magnetic Resonance Imaging 
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Table 6: Results of multinomial logistic regression of predictors on MRI findings of atrophy (model 
fitted to N=384) 
 
Outcome relative to no atrophy Predictor Relative Risk Ratio 95% CI p value 
Mild Atrophy 
Age 1.01 0.96 to 1.06 0.68 
Gender (Male) 1.58 0.81 to 3.09 0.18 
CAMCOG 1.02 0.99 to 1.05 0.22 
Hachinski ≥ 1 0.72 0.35 to 1.48 0.38 
Moderate Atrophy 
Age 1.03 0.98 to 1.08 0.28 
Gender (Male) 1.92 1 to 3.67 0.048 
CAMCOG 0.99 0.97 to 1.02 0.57 
Hachinski ≥ 1 1.19 0.62 to 2.29 0.6 
Severe atrophy 
Age 1 0.95 to 1.07 0.87 
Gender (Male) 3.03 1.38 to 6.67 0.006 
CAMCOG 0.97 0.94 to 1.00 0.05 
Hachinski ≥ 1 1.36 0.62 to 3.00 0.45 
Regional Atrophy 
Age 1 0.95 to 1.04 0.88 
Gender (Male) 2.24 1.26 to 3.99 0.006 
CAMCOG 0.98 0.96 to 1.00 0.028 
Hachinski ≥ 1 0.75 0.41 to 1.38 0.36 
 
CAMCOG = Cambridge Cognitive Examination, CI = Confidence Interval 
Table 7: Results of logistic regression of predictors against MRI findings of vascular pathology (model 
fitted to N=384) 
 
Predictor Odds ratio 95% CI p value 
Age 1.08 1.05 to 1.11 <0.001 
Gender (Male) 0.52 0.35 to 0.76 <0.001 
CAMCOG 0.99 0.98 to 1.01 0.25 
Hachinski ≥ 1 1.36 0.91 to 2.02 0.13 
 
CAMCOG = Cambridge Cognitive Examination, CI = Confidence Interval  
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Figure 1: Flow Diagram to show study inclusion and exclusion 
 
 
MRI = Magnetic Resonance Imaging  
Overall Database: 
Data collected as part of 
routine clinical practice from 
referrals to memory 
assessment service (n=652) 
Met Inclusion criterion: 
Received formal dagnosis of 
dementia (n=502) 
Other Outcomes: 
• No pathological findings (n = 33) 
• Mild cognitive Impairment 
(n=104) 
• Depression (n=7) 
• Alcoholic dementia (n=4) 
• Normal Pressure Hydrocephalus 
(n=1) 
• Intracranial tumour (n=1) 
Study Population: 
Eligible for study (n=469) 
Excluded from study: 
• Unsuitable for MRI scan (n=28) 
• Imaging performed by another 
centre (n=2) 
Met Inclusion Criterion:  
Had MRI scan completed and 
graded at local neuroimaging 
centre (n=472) 
Excluded from study: 
• Missing or incomplete MRI 
outcome data (n=3) 
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Figure 2: Plot to show the predicted probability of atrophy findings on MRI against varying CAMCOG, 
gender and HIS 
  
 
MRI = Magnetic Resonance Imaging, CAMCOG = Cambridge Cognitive Examination   
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Figure 3: Plot to show the predicted probability of vascular findings on MRI against varying age, 
gender and HIS  
 
 
MRI = Magnetic Resonance Imaging, HIS = Hachinski Ischemic Score 
